{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T13:17:59Z","timestamp":1780492679802,"version":"3.54.1"},"reference-count":48,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:00:00Z","timestamp":1644192000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Metabolism Res"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>SIRT1 exerts effects on ageing and lifespan, as well cardiovascular (CV) disease risk. SIRT1 gene is very polymorph with a few tagging single nucleotide polymorphisms (SNPs) so far identified. Some SNPs, including rs7896005, were associated with type 2 diabetes (T2DM). We aimed to ascertain whether this SNP may be associated with CV disease at baseline as well with these same outcomes and all\u2010cause mortality over a 13\u2010year follow\u2010up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>Genotypes of SIRT1 gene were determined using TaqMan SNP assay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Out of 905 T2DM, 9.1% had the AA genotype, 43.2% the AG, and 47.7% the GG. Hardy\u2013Weinberg Equilibrium was met (minor allele frequency 0.306;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.8899). At baseline, there was no difference across genotypes for sex, age, diabetes duration, CV risk factors, treatments, and microangiopathy. Major CV outcomes, myocardial infarction (MI), any coronary heart disease (CHD), and peripheral artery disease (PAD) were more frequent in GG than in AA\/AG (\n                      <jats:italic>p<\/jats:italic>\n                      from 0.013 to 0.027), with no association with cerebrovascular events. By fully adjusted regression, GG remained independently related to major CV outcomes, MI, CHD, and PAD. Over follow\u2010up, we recorded 258 major CV events (28.5%; AA\/AG 25.2%, GG 32.2%;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.014) with an adjusted hazard ratio (HR) of GG versus AA\/AG of 1.296 (95% CI 1.007\u20131.668,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.044); 169 coronary events (18.7%; AA\/AG 15.4%, GG 22.2%;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.006) with HR 1.522 (1.113\u20132.080,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.008); 79 (8.7%) hospitalisation for heart failure (AA\/AG 7.0%, GG 10.6%;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.045) and HR 1.457 (0.919\u20132.309,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.109); 36 PAD (4.0%; AA\/AG 2.3%, GG 5.8%;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.007) with HR 2.225 (1.057\u20134.684,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.035). No association was found with cerebrovascular events, end stage renal disease, and all\u2010cause mortality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The rs7896005 SNP of SIRT1 might play a role in cardiovascular disease, mainly CHD risk in T2DM. Results call for larger association studies as well as studies to ascertain mechanisms by which this variant confers increased risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/dmrr.3523","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T05:29:48Z","timestamp":1643434188000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["<i>SIRT1<\/i>\n                    rs7896005 polymorphism affects major vascular outcomes, not all\u2010cause mortality, in Caucasians with type 2 diabetes: A 13\u2010year observational study"],"prefix":"10.1002","volume":"38","author":[{"given":"Angela","family":"Dardano","sequence":"first","affiliation":[{"name":"Section of Diabetes and Metabolic Disease Department of Clinical and Experimental Medicine University of Pisa and Azienda Ospedaliero\u2010Universitaria Pisana  Pisa Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Lucchesi","sequence":"additional","affiliation":[{"name":"Section of Diabetes and Metabolic Disease Department of Clinical and Experimental Medicine University of Pisa and Azienda Ospedaliero\u2010Universitaria Pisana  Pisa Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monia","family":"Garofolo","sequence":"additional","affiliation":[{"name":"Section of Diabetes and Metabolic Disease Department of Clinical and Experimental Medicine University of Pisa and Azienda Ospedaliero\u2010Universitaria Pisana  Pisa Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Gualdani","sequence":"additional","affiliation":[{"name":"Epidemiology Unit Regional Health Agency (ARS) of Tuscany  Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierpaolo","family":"Falcetta","sequence":"additional","affiliation":[{"name":"Section of Diabetes and Metabolic Disease Department of Clinical and Experimental Medicine University of Pisa and Azienda Ospedaliero\u2010Universitaria Pisana  Pisa Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Sancho Bornez","sequence":"additional","affiliation":[{"name":"Section of Diabetes and Metabolic Disease Department of Clinical and Experimental Medicine University of Pisa and Azienda Ospedaliero\u2010Universitaria Pisana  Pisa Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Francesconi","sequence":"additional","affiliation":[{"name":"Epidemiology Unit Regional Health Agency (ARS) of Tuscany  Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Del Prato","sequence":"additional","affiliation":[{"name":"Section of Diabetes and Metabolic Disease Department of Clinical and Experimental Medicine University of Pisa and Azienda Ospedaliero\u2010Universitaria Pisana  Pisa Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Penno","sequence":"additional","affiliation":[{"name":"Section of Diabetes and Metabolic Disease Department of Clinical and Experimental Medicine University of Pisa and Azienda Ospedaliero\u2010Universitaria Pisana  Pisa Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,2,7]]},"reference":[{"key":"e_1_2_12_2_1","first-page":"313","article-title":"A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: part 2","volume":"15","author":"Kelly GS","year":"2010","journal-title":"Alternative Med Rev"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R112.378877"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pathol.4.110807.092250"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-019-0158-9"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2011.08.001"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00187"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2018.74757"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.3727\/105221615X14399878166195"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048621"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1203"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2010.06.030"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10522-011-9360-5"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058636"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/62.9.960"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2005.09.008"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-016-0293-3"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glx018"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv290"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2017.7178"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00053.2015"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090428"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00614"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-014-0112-7"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115339"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2018.05.117"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2008.12.022"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/kisup.2012.73"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(03)00475-5"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2012.03644.x"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/1932296814527818"},{"key":"e_1_2_12_32_1","first-page":"203","volume-title":"The Minnesota Code Manual of Electrocardiographic Findings","author":"Prineas RJ","year":"1982"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.jrn.2011.10.025"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2014.00166"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13105-013-0268-1"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2015.157"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-011-0418-0"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-103966"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.2337\/db09-0536"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2011.200"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.05.043"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-020-0339-2"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2017.7290"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2015.03.001"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2014.10.036"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012959"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.09.037"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12975-013-0277-y"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2017.7258"}],"container-title":["Diabetes\/Metabolism Research and Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/dmrr.3523","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/dmrr.3523","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/dmrr.3523","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T12:08:30Z","timestamp":1692965310000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/dmrr.3523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,7]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["10.1002\/dmrr.3523"],"URL":"https:\/\/doi.org\/10.1002\/dmrr.3523","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1002\/DMRR.3523\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/DMRR.3523\/v2\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/DMRR.3523\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/DMRR.3523\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/DMRR.3523\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/DMRR.3523\/v1\/review2","asserted-by":"object"}]},"ISSN":["1520-7552","1520-7560"],"issn-type":[{"value":"1520-7552","type":"print"},{"value":"1520-7560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,7]]},"assertion":[{"value":"2021-08-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-31","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e3523"}}